Feops, a life sciences spin-out of Ghent University founded in 2009, has raised €1.3m ($1.5m) in its series A in a round led by Capricorn Venture Partners and PMV.
Funding from the round will be used to support the launch of Feops first product, TaviGuide, in the US and Europe. TaviGuide will provide a pre-operation patient-specific 3D simulation for cardiovascular surgery.
Matthieu De Beule, CEO of FEops, said: “The current series A financing round enables us to bring this novel technology as a cloud service from the bench to the bedside and paves the way for developing a portfolio of physics-based simulation planning tools for other cardiovascular procedures. We appreciate the support and trust of a syndicate of strong investors and are pleased to welcome Marc Lambrechts and Alexandra Tolia to our Board of Directors.”
